NYSE:DIS charts & data provided by TradingView

Latest Insights on DIS

Buying, selling, laughing? Anything goes in this market. Hear how Great Stuff readers stay sane amid the insanity. Have Feedback, Will Travel: Economy, Cruises and Puts October 29, 2020 by Joseph Hargett Great Stuff The “All of the Above” Economy ‘Sup, Great Ones? Welcome to Reader Feedback day! Today, as always, is about you. Your stock market questions. Your investment hopes. Your Wall Street rants. Your deepest options desires. Um … desires, Mr. Great Stuff? Don’t worry, I won’t pull any of that Tom Ellis Lucifer mojo on you. […]
How to Find Tech’s Next 10X Winners October 29, 2020 by Brian Christopher Investment Opportunities, Technology, Winning Investor Daily Many of you have heard about the new technologies already among us. But have you ever wondered how to play them?
You know what they say about baseball card collecting in the ‘80s and the stock market. Well, maybe you don’t, but it ain’t pretty… Winter Is Coming; Forests of Azure, Cloudless Solar Skies October 28, 2020 by Joseph Hargett Great Stuff Future in the Cards Sooo … how about those Dodgers? I don’t follow baseball — I got burned on baseball cards back in the late ‘80s and early ‘90s, and it’s been downhill ever since. Anyone else have a massive box of three-decades-old baseball cards that are worth absolutely nothing right now? Oddly enough, there’s […]
It’s the changing of the guard. A capitalist election of the highest order. Intel is no longer inside. Behold AMD’s ascent! AMD Ascends; S&P Double-Plus Bad; Leaving Las Vegas October 27, 2020 by Joseph Hargett Great Stuff House of the Ryzen Sun Great Ones, we’re watching an era end in the semiconductor market. A changing of the guard. A capitalist election of the highest order. No longer does “Intel Inside” rule the roost. Behold AMD’s ascent. Okay, somebody’s got delusions of grandeur. Too much Death Wish coffee this morning? What gives, Mr. […]
Invest in Biotech With 1 Buy October 27, 2020 by Chad Shoop 2020 Financial Crisis, American Investor Today (9-minute video) In the war against COVID-19, American biotech companies are paving the path. The latest success is Gilead’s remdesivir winning FDA approval. Will this be the start of a new uptrend for the stock?

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

“Loving the 238% gain after I bought your recommendation in Sept. 2019! This week (July 21, 2020) will be my 1 year anniversary with your amazing team … thanks for the life-changing work you all do! Between all your services, 14 triple-digit gains, the greatest at 358%!"

- Matt

Share This